Roche Cuts Cancer Drug Price In U.K.
Roche is cutting the price of its its lung cancer treatment Tarceva by about $1,000 to win approval for its usage from the U.K.’s National Institute for Health and Clinical Excellence. (Pharmalot)
The Curator finds, summarizes, and links to the highest-quality, most authoritative online sources of business and political news and information: breaking news, analysis, background and opinion. Learn more »
Have something you'd like to share?
Is there an important story you think we should cover or features you would like added? Let us know »
Roche is cutting the price of its its lung cancer treatment Tarceva by about $1,000 to win approval for its usage from the U.K.’s National Institute for Health and Clinical Excellence. (Pharmalot)
Categories: Biotech, Pharma · Business & Finance Today
No Comments Yet
You can be the first to comment!
Leave a comment